https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Oveporexton Demonstrates Statistically Significant, Clinically Meaningful Improvements in Patients With NT1

Oveporexton Demonstrates Statistically Significant, Clinically Meaningful Improvements in Patients With NT1

In 2 clinical trials, oveporexton shows promise in treating narcolepsy type 1 (NT1), paving the way for potential FDA approval.

administrator

Related Articles